Erythropoiesis-stimulating Agent [EPC]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Erythropoiesis-stimulating Agent [EPC] includes 2 drugs with a combined 39,789 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
39,789
Combined Reports
All Erythropoiesis-stimulating Agent [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| DARBEPOETIN ALFA | ARANESP | 32,763 | 13,865 | 14,279 | 42.3% |
| METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA | Mircera | 7,026 | 1,352 | 1,323 | 19.2% |
Common Side Effects in Erythropoiesis-stimulating Agent [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Death | 13,037 | 13,030 |
| Hospitalisation | 5,722 | 1,168 |
| Drug hypersensitivity | 3,079 | 131 |
| Off label use | 1,676 | 369 |
| Product storage error | 1,643 | 4 |
| Dyspnoea | 1,453 | 179 |
| Nausea | 1,114 | 255 |
| Circumstance or information capable of leading to medication error | 1,050 | 0 |
| Vomiting | 972 | 272 |
| Haemodialysis | 926 | 65 |